FindTrial
Sign In

Feasibility and Safety of Transjugular Liver Biopsy for Japanese Patients with Chronic Liver Diseases

Feasibility and Safety of Transjugular Liver Biopsy for Japanese Patients with Chronic Liver Diseases - Feasibility and Safety of Transjugular Liver Biopsy for Japanese Patients with Chronic Liver Diseases

Status
Recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000043028
Enrollment
134
Registered
2021-01-16
Start date
2021-01-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Liver Diseases

Interventions

None listed

Sponsors

Dokkyo Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Between July 2014 and February 2019, a total of 134 patients underwent liver biopsies at our institution.

Exclusion criteria

Exclusion criteria: Even patients with prothrombin activity <20% and platelets >30,000/mm3

Design outcomes

Primary

MeasureTime frame
The primary endpoints of this study were the utility and safety of TJLB in patients who were not indicated for PLB.—

Countries

Japan

Contacts

Public ContactAkira Yamamiya

Dokkyo Medical University Department of Gastroenterology

akira-y@dokkyomed.ac.jp0282872147

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026